Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in … Read more
Market Cap & Net Worth: Rapid Dose Therapeutics Corp (RDTCF)
Rapid Dose Therapeutics Corp (PINK:RDTCF) has a market capitalization of $24.27 Million ($24.27 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #28279 globally and #9434 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rapid Dose Therapeutics Corp's stock price $0.18 by its total outstanding shares 134819129 (134.82 Million).
Rapid Dose Therapeutics Corp Market Cap History: 2019 to 2025
Rapid Dose Therapeutics Corp's market capitalization history from 2019 to 2025. Data shows change from $41.89 Million to $24.27 Million (-18.87% CAGR).
Rapid Dose Therapeutics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rapid Dose Therapeutics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
11.64x
Rapid Dose Therapeutics Corp's market cap is 11.64 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $29.93 Million | $101.50K | -$7.96 Million | 294.88x | N/A |
| 2021 | $55.28 Million | $755.20K | -$1.80 Million | 73.19x | N/A |
| 2022 | $2.70 Million | $1.75 Million | -$8.49 Million | 1.54x | N/A |
| 2023 | $2.04 Million | $718.30K | -$3.81 Million | 2.83x | N/A |
| 2024 | $24.47 Million | $1.02 Million | -$4.31 Million | 23.99x | N/A |
| 2025 | $24.27 Million | $2.09 Million | -$5.40 Million | 11.64x | N/A |
Competitor Companies of RDTCF by Market Capitalization
Companies near Rapid Dose Therapeutics Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Rapid Dose Therapeutics Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Rapid Dose Therapeutics Corp Historical Marketcap From 2019 to 2025
Between 2019 and today, Rapid Dose Therapeutics Corp's market cap moved from $41.89 Million to $ 24.27 Million, with a yearly change of -18.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $24.27 Million | -0.83% |
| 2024 | $24.47 Million | +1101.99% |
| 2023 | $2.04 Million | -24.50% |
| 2022 | $2.70 Million | -95.12% |
| 2021 | $55.28 Million | +84.68% |
| 2020 | $29.93 Million | -28.55% |
| 2019 | $41.89 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Rapid Dose Therapeutics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.27 Million USD |
| MoneyControl | $24.27 Million USD |
| MarketWatch | $24.27 Million USD |
| marketcap.company | $24.27 Million USD |
| Reuters | $24.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.